1.22

2.52% 0.03

Inovio Pharmaceuticals Inc (INO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.19

Aprire:

$1.2

Volume 24 ore:

2.76M

Relative Volume:

1.00

Capitalizzazione di mercato:

$100.37M

Reddito:

$65,300

Utile/perdita netta:

$-84.93M

Rapporto P/E:

-0.7143

EPS:

-1.708

Flusso di cassa netto:

$-83.57M

1 W Prestazione:

+12.96%

1M Prestazione:

+0.83%

6M Prestazione:

-27.81%

1 anno Prestazione:

-42.99%

Intervallo 1D:

$1.18

$1.27

Intervallo di 1 settimana:

$1.075

$1.27

Portata 52W:

$1.03

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Nome

Inovio Pharmaceuticals Inc

Settore

Healthcare (1098)

Industria

Biotechnology (615)

Telefono

(858) 410-3134

Indirizzo

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Dipendente

112

Cinguettio

@inoviopharma

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INO Inovio Pharmaceuticals Inc	1.22	90.50M	65,300	-84.93M	-83.57M	-1.708
VRTX Vertex Pharmaceuticals Inc	528.04	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	654.27	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	939.68	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	312.78	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.24	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-09	Iniziato	Piper Sandler	Overweight
2024-05-14	Iniziato	Stephens	Overweight
2024-01-25	Aggiornamento	Oppenheimer	Perform → Outperform
2022-11-09	Downgrade	Maxim Group	Buy → Hold
2022-11-01	Downgrade	BofA Securities	Neutral → Underperform
2022-07-19	Ripresa	RBC Capital Mkts	Sector Perform
2022-05-11	Downgrade	Oppenheimer	Outperform → Perform
2022-01-21	Aggiornamento	BofA Securities	Underperform → Neutral
2021-12-29	Ripresa	Jefferies	Hold
2021-09-10	Downgrade	BofA Securities	Neutral → Underperform
2021-06-24	Iniziato	Jefferies	Hold
2021-03-23	Iniziato	BofA Securities	Neutral
2021-02-12	Iniziato	Oppenheimer	Outperform
2020-11-17	Downgrade	ROTH Capital	Neutral → Sell
2020-11-10	Aggiornamento	ROTH Capital	Sell → Neutral
2020-09-28	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Aggiornamento	Maxim Group	Hold → Buy
2020-07-01	Downgrade	Maxim Group	Buy → Hold
2020-07-01	Downgrade	ROTH Capital	Neutral → Sell
2020-06-29	Downgrade	H.C. Wainwright	Buy → Neutral
2020-06-26	Downgrade	Stifel	Buy → Hold
2020-05-21	Iniziato	The Benchmark Company	Buy
2020-04-30	Downgrade	ROTH Capital	Buy → Neutral
2020-03-13	Downgrade	Piper Sandler	Overweight → Neutral
2020-03-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Iniziato	ROTH Capital	Buy
2018-02-15	Reiterato	Maxim Group	Buy
2017-10-18	Iniziato	RBC Capital Mkts	Outperform
2017-09-06	Iniziato	Citigroup	Buy
2017-06-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-05-24	Reiterato	Maxim Group	Buy
2017-03-16	Aggiornamento	Maxim Group	Hold → Buy
2017-03-16	Downgrade	Piper Jaffray	Overweight → Neutral

Mostra tutto

Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie

Jun 30, 2026

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 30, 2026

INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits

Jun 30, 2026

Jun 29, 2026

Inovio Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch

Jun 29, 2026

Jun 28, 2026

Inovio Pharmaceuticals, Inc.(NasdaqCM: INO) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Inovio Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INO) - TradingView

Jun 27, 2026

Price to earnings forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView

Jun 27, 2026

Price to sales forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView

Jun 27, 2026

Enterprise value to revenue forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView

Jun 27, 2026

Jun 26, 2026

Inovio Pharmaceuticals, Inc. Actuals & Estimates (BX:GBM) - TradingView

Jun 26, 2026

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026

INO stock edges up after hours as partner reports success in cervical dysplasia trial - MSN

Jun 26, 2026

Jun 25, 2026

Inovio Pharmaceuticals, Inc. Actuals & Estimates (DUS:GBM) - TradingView

Jun 25, 2026

Inovio Pharmaceuticals, Inc. Actuals & Estimates (BMV:INO) - TradingView

Jun 25, 2026

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jun 25, 2026

INO Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026